Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Kamal Alkeay"'
Publikováno v:
Glomerular Diseases, Vol 4, Iss 1, Pp 84-90 (2024)
Introduction: Alemtuzumab, a humanized monoclonal antibody indicated for the treatment of adult patients with active relapsing-remitting multiple sclerosis (MS), has been associated with increased risk of autoimmune adverse events, including thyroid
Externí odkaz:
https://doaj.org/article/0c92a73676644c3f909630c7a6a0611c
